As influencers promote the use of Melanotan II, known as the 'Barbie peptide' for its tanning effects, concerns arise regarding its safety and regulatory status. Experts warn about the potential health risks associated with unregulated peptide use, including serious side effects…
New research indicates that creatine, a widely used supplement among athletes, may have unpredictable effects on blood pressure. While some studies suggest slight reductions in bl…
The Targeting Aging with Metformin (TAME) trial aims to investigate whether metformin, a widely used diabetes medication, can slow biological aging and extend lifespan. This multi…
The FDA has granted approval for Mounjaro (tirzepatide) to reduce cardiovascular risk in individuals with type 2 diabetes, marking a significant development in diabetes management…
Recent advancements in blood testing for Alzheimer's disease risk assessment may revolutionize early detection and diagnosis. Approved by the FDA, tests measuring amyloid and tau…
The FDA is signaling a desire for stronger oversight of the Generally Recognized As Safe (GRAS) process that allows many supplement ingredients to enter the market without formal…
The FDA has approved Eli Lilly's medication Mounjaro for reducing the risk of heart events in individuals with Type 2 diabetes. This approval adds to the drug's existing use for b…
This article examines the potential of GLP-1 receptor agonists, commonly used for type 2 diabetes and obesity, in treating polyendocrine metabolic ovarian syndrome (PMOS). Experts…
As the popularity of weight-loss drugs like GLP-1 receptor agonists grows, a black market for the unapproved drug retatrutide has emerged, alarming health experts. Developed by El…
GLP-1 medications, known for their role in treating diabetes and obesity, are being studied for additional health benefits, including improvements in heart health and potential ca…
The FDA has granted clearance for a new treatment for post-traumatic stress disorder (PTSD) that utilizes Magnetic e-Resonance Therapy (MeRT). Developed by Wave Neuroscience in co…
Bud Leavell, a 72-year-old Parkinson's patient, experienced a remarkable improvement when his yearslong tremor vanished within minutes of receiving a new FDA-approved focused ultr…
In an ambitious move, RFK Jr. aims to ease access to unapproved peptide drugs, assuring patients they’ll receive a 'more controlled alternative' while keeping the actual safety of…
Anavex Life Sciences is making strides in its Phase 3 planning for Alzheimer's disease with the FDA, having submitted clinical trial data and reporting a cash position of $118.3 m…